Denali Therapeutics Stock Quote DNLI - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

20.51

Bid

19.95

Ask

21.22

Volume

750,216

19.945 Day's Range 20.78

14.56 52 Week Range 33.31

Market Cap

2.858B

Previous Close

20.24

Open

20.30

Last Trade

200

20.51

(priorref)

Last Trade Time

Financial Volume

$ 15,316,768

VWAP

20.4165

Average Volume (3m)

1,217,975

Shares Outstanding

139,160,239

Dividend Yield

PE Ratio

-19.68

Earnings Per Share (EPS)

-1.04

Revenue

330.53M

Net Profit

-145.22M

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.denalitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $20.24. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 14.56 to $ 33.31.

Denali Therapeutics currently has 139,160,239 shares outstanding. The market capitalization of Denali Therapeutics is $2.86 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -19.68.

Form 8-K - Current report

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial

SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.67	8.86411889597	18.84	20.91	18.27	963328	19.87026506	CS
4	4.01	24.303030303	16.5	20.91	14.56	1203555	17.23005051	CS
12	3.68	21.8657159834	16.83	23.52	14.56	1217975	19.07608057	CS
26	2.1	11.4068441065	18.41	23.81	14.56	1136217	18.96644045	CS
52	-8.91	-30.2855200544	29.42	33.31	14.56	944686	21.2323966	CS
156	-33.18	-61.7992177314	53.69	79.7	14.56	739995	30.27624301	CS
260	0.1	0.489955903969	20.41	93.94	12.39	654360	32.65389629	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.67M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.22M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.33M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.73B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.3M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.2M